(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
James W Green, Director, Chief Executive Officer, on June 15, 2022, executed a purchase for 30,000 shares in Harvard Bioscience (HBIO) for $111,300....
...
...
| Address | 84 October Hill Road Holliston, Massachusetts 01746-1371 |
| Phone | +1.508.893.8999 |
| Number of Employees | 547 |
| Recent SEC Filing | 08/04/2022 8-K |
| Chairman, President & Chief Executive Officer | James W. Green |
| Chief Financial Officer | Michael A. Rossi |
| Vice President-Global Sales, Preclinical Systems | Ryan Wallace |
| Chief Marketing Officer | Jacques Coumans |
| Price Open | $3.38 |
| Previous Close | $3.36 |
| 52 Week Range | $3.25 - 8.75 |
| Market Capitalization | $138.6 M |
| Shares Outstanding | 41.6 M |
| Sector | Health Technology |
| Industry | Biotechnology | Next Earnings Announcement | 11/02/2022 |
| Call Open Interest (1d)* |  |
| Put Open Interest (1d)* | |
| Call Volume (1d)* | |
| Put Volume (1d)* | |
| Put Call Open Interest Ratio (1d)* | |
| Put Call Volume Ratio (1d)* | |
| * Data delayed by up to 15 minutes |
| Price / Earnings | N/A |
| Earnings per Share | -$0.08 |
| Beta vs. S&P 500 | N/A |
| Revenue | $120.8 M |
| Net Profit Margin | -3.03% |
| Return on Equity | -4.65% |
| Buy | |
| Overweight | |
| Hold | |
| Underweight | |
| Sell | |
Consensus Recommendation | |
